The prevalence and impact of migraine and severe headache in the United States: figures and trends from government health studies R Burch, P Rizzoli, E Loder Headache: The Journal of Head and Face Pain 58 (4), 496-505, 2018 | 576 | 2018 |
The 2012 AHS/AAN guidelines for prevention of episodic migraine: a summary and comparison with other recent clinical practice guidelines E Loder, R Burch, P Rizzoli Headache: The Journal of Head and Face Pain 52 (6), 930-945, 2012 | 328 | 2012 |
The prevalence and impact of migraine and severe headache in the United States: Updated age, sex, and socioeconomic‐specific estimates from government health surveys R Burch, P Rizzoli, E Loder Headache: The Journal of Head and Face Pain 61 (1), 60-68, 2021 | 214 | 2021 |
Tension-type headache E Loder, P Rizzoli Bmj 336 (7635), 88-92, 2008 | 159 | 2008 |
Association of coprescription of triptan antimigraine drugs and selective serotonin reuptake inhibitor or selective norepinephrine reuptake inhibitor antidepressants with … Y Orlova, P Rizzoli, E Loder JAMA neurology 75 (5), 566-572, 2018 | 103 | 2018 |
Medication overuse headache: an entrenched idea in need of scrutiny AI Scher, PB Rizzoli, EW Loder Neurology 89 (12), 1296-1304, 2017 | 89 | 2017 |
Safety findings from phase 3 lasmiditan studies for acute treatment of migraine: results from SAMURAI and SPARTAN JH Krege, PB Rizzoli, E Liffick, EG Doty, SA Dowsett, J Wang, ... Cephalalgia 39 (8), 957-966, 2019 | 81 | 2019 |
Pharmacologic prevention of migraine: a narrative review of the state of the art in 2018 E Loder, P Rizzoli Headache: The Journal of Head and Face Pain 58, 218-229, 2018 | 74 | 2018 |
Hormonal Management of Migraine Associated With Menses and the Menopause: A Clinical Review: CME E Loder, P Rizzoli, J Golub Headache: The Journal of Head and Face Pain 47 (2), 329-340, 2007 | 74 | 2007 |
Acute and preventive treatment of migraine PB Rizzoli Continuum: Lifelong Learning in Neurology 18 (4), 764-782, 2012 | 71 | 2012 |
Preventive pharmacotherapy in migraine P Rizzoli Headache: The Journal of Head and Face Pain 54 (2), 364-369, 2014 | 64 | 2014 |
Vestibular migraine: treatment and prognosis M von Brevern, T Lempert Seminars in neurology 40 (01), 083-086, 2020 | 56 | 2020 |
Headache in patients with pituitary lesions: a longitudinal cohort study P Rizzoli, S Iuliano, E Weizenbaum, E Laws Neurosurgery 78 (3), 316-323, 2016 | 54 | 2016 |
ACT for migraine: Effect of acceptance and commitment therapy (ACT) for high-frequency episodic migraine without aura: Preliminary data of a phase-II, multicentric, randomized … L Grazzi, C Bernstein, A Raggi, E Sansone, E Grignani, M Searl, P Rizzoli Neurological Sciences 40, 191-192, 2019 | 42 | 2019 |
The comorbidity burden of patients with cluster headache: a population-based study S Joshi, P Rizzoli, E Loder The Journal of Headache and Pain 18, 1-9, 2017 | 37 | 2017 |
Tolerance and loss of beneficial effect during migraine prophylaxis: clinical considerations EW Loder, P Rizzoli Headache: The Journal of Head and Face Pain 51 (8), 1336-1345, 2011 | 36 | 2011 |
Amitriptyline dose and treatment outcomes in specialty headache practice: a retrospective cohort study L Doyle Strauss, E Weizenbaum, EW Loder, PB Rizzoli Headache: The Journal of Head and Face Pain 56 (10), 1626-1634, 2016 | 33 | 2016 |
Biomarkers in migraine: their promise, problems, and practical applications E Loder, P Rizzoli Headache: The Journal of Head and Face Pain 46 (7), 1046-1058, 2006 | 33 | 2006 |
Emerging therapeutic options for acute migraine: focus on the potential of lasmiditan PB Rizzoli Neuropsychiatric disease and treatment, 547-552, 2014 | 31 | 2014 |
Tolerance to the beneficial effects of prophylactic migraine drugs: a systematic review of causes and mechanisms P Rizzoli, EW Loder Headache: The Journal of Head and Face Pain 51 (8), 1323-1335, 2011 | 30 | 2011 |